Project Grant R01CA301727
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$641K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) supports research to modulate the human microbiome to enhance immune responses against cancer. The $179,988 award to The Leland Stanford Junior University, a private research university, aims to identify bacterial functions that can improve response to immune checkpoint blockade cancer therapies. Key objectives include: Aggregating and analyzing metagenomic data to identify microbial genes...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding of $684,367 to support research aimed at identifying intratumoral microbiome profiles and spatial immune signatures that can predict response to immune checkpoint inhibitor therapy in patients with non-small cell lung cancer. The project, led by researchers at Baylor College of Medicine, will analyze pre-treatment tumor samples from three independent cohorts (totaling...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) will fund research to define novel mechanisms by which the gut microbiota (trillions of microbes in the intestine) influence anti-tumor immunity and the response to cancer immunotherapies. The $138,240 award to Weill Medical College of Cornell University will support studies to understand how host-microbiota interactions promote tumor growth by limiting metabolites that...
This Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) provides $360,100 in funding to The Leland Stanford Junior University from August 2024 to February 2027. The purpose of the award is to investigate the role of antigen-presenting cells in promoting tumor-specific immune tolerance and metastatic progression, and to develop immunotherapeutic strategies to overcome this mechanism. The research involves using high-dimensional imaging,...
This Project Grant award of $1,158,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research at Stanford University focused on understanding and engineering cellular recognition and multicellular organization for cancer immunotherapy applications. The research aims to advance the use of engineered T cells for targeting solid tumors by exploring mechanisms to enhance T cell specificity and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research program) provides $424,734 to the University of Illinois to develop a novel spatial proteomics approach integrating 3D microscopy and bottom-up proteomic analysis. The goal is to offer deep proteome profiles of specific immune cells within different subregions of a tumor, in order to understand the spatially associated functions of immune cells in the tumor microenvironment. The project...
The National Cancer Institute (NCI) awarded a $537,985 Project Grant through the Cancer Biology Research (CFDA 93.396) federal grant program to the University of Texas MD Anderson Cancer Center. The grant, which runs from August 1, 2024 to July 31, 2029, supports research to deeply characterize the location, distribution, and spatial functionality of microbes within the tumor microenvironment of primary pancreatic tumors, as well as their influence on tumor growth, pre-metastatic niche...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the University of Texas MD Anderson Cancer Center (MD Anderson) will fund research to define the landscape of bacterial-colonized microniches within tumors and their role in intratumoral heterogeneity. The total award of $626,893 will be provided over a 5-year period from September 1, 2024 to August 31, 2029. The key products or services to be delivered under this grant include:...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) supports a research project titled "Mapping Intercellular Protein Trafficking in Glioblastoma with Esterase-Activated Proximity Labeling" at The Leland Stanford Junior University. The $170,655 award, effective July 1, 2025 through June 30, 2027, aims to develop a new molecular method for mapping protein translocation between glioblastoma (GBM) cells and other brain...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $364,324 to The Leland Stanford Junior University to study the regulatory role of microbially-derived metabolites on the host immune system, particularly the impact on macrophages. The research aims to determine the metabolic pathways responsible for producing immune-associated microbial...